Searched for
MYNVAX
HCG founder floats $20 million healthcare and life sciences fundBS Ajaikumar launched the $20 million Inviga Healthcare Fund to support Indian early-stage healthcare companies, addressing funding and ope...- India's 'warm' vaccine candidate effective against Delta, Omicron variants in mice: StudyThe heat-tolerant COVID-19 vaccine candidate can be stored at 37 degrees Celsius for four weeks and at 100 degrees Celsius for up to 90 min...
- Info Edge digs in; rules for crypto ads; Mamaearth valued at $730MInfo Edge founder told us the company plans to hold on to the bulk of its 15% stake in Zomato.
- Inside IISc Bangalore's Incubation LabIndian Institute of Science Bangalore's (IISc Bangalore) Society for Innovation and Development has turned into a hub of deep science start...
- BharatPe banks on engineersIn today's ETtech Morning Dispatch: Making sense of BharatPe's banking foray; Mastercard ban gives Visa all the power; Over 150,000 IT jobs...
- Blackstone's edtech bet; GlobalBees and Spinny score bigFrom Blackstone's newest edtech bet to GlobalBees's $150 million fundraising and the latest on the Pegasus spyware, here's a quick look at ...
- IISc-incubated Mynvax raises $4.2 million to develop ‘warm’ Covid-19 vaccineUnlike Covishield, Covaxin and Russia’s Sputnik V, Mynvax’s Covid-19 vaccine molecule is thermostable and can be stored at room temperature.
- IISc's 'warm' Covid vaccine effective against all major variants of concern: StudyAccording to S S Vasan, CSIRO's COVID-19 project leader and co-author of the study, the Mynvax-vaccinated mice sera show a strong response ...
- Warm vaccine, Lukewarm response: IISc’s homegrown Covid-19 vaccine hits funding wallThe indigenous heat-stable vaccine, once cleared for use, will best suit India’s weather and could potentially revolutionise vaccine delive...
- Indian researchers working towards developing effective vaccine strategies against SARS-CoV-2 and HIVIn two studies published in the past week, they reported the design of a 'heat-tolerant' Covid-19 vaccine candidate and a rapid method to i...
- Aurobindo ties up with Biotechnology Industry Research Assistance Council for COVID-19 vaccineAurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate ...
- 'Excellent safety' of 2 indigenous COVID candidate vaccines revealed during Phase-I trials: MinisterSerum Institute of India (SII) and ICMR have partnered for clinical development of two global vaccine candidates.
- For a winning portfolio in medium term, don't overlook quality laggards: Manishi Raychaudhuri'For those who have to stay invested, we are recommending large compounders and allocating to quality laggards.'
- Seven Indian pharmaceutical companies race to develop vaccine for deadly coronavirusBharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma...
- Mynvax, IIsc-incubated startup looks at Covid-19 vaccine in 18 monthsThe startup, incubated at the Indian Institute of Science, Bengaluru, also said it was critical to build capability to produce the vaccine ...
- COVID-19 vaccine development at early stage in India; breakthrough unlikely within a year: ExpertsReferring to a vaccine to fight the virus, a PMO statement had said that it is the most pressing need and Indian academia, start-ups and in...
- Equity not always the best place to be, asset allocation important: Shankar SharmaDiversify across at least 25 stocks and have sectoral diversification, says Vice Chairman & Joint MD, First Global.
- Six Indian companies working on COVID-19 vaccine, many challenges in finding a preventive: ExpertsNearly 70 'vaccine candidates' are being tested and at least three have moved to the human clinical trial stage, but a vaccine for the nove...
Load More
